Synergistic antitumor effect of histone deacetylase class IIa inhibitor with lenvatinib in hepatocellular carcinoma
Ryo Ito, Koji Miyanishi, Tomohiro Kubo, Kota Hamaguchi, Takahiro Osuga, Shingo Tanaka, Hiroyuki Ohnuma, Kazuyuki Murase, Kohichi Takada, Minoru Nagayama, Yasutoshi Kimura, Toru Mizuguchi, Ichiro Takemasa, Junji Kato
Topics & Concepts
LenvatinibMedicineCancer researchHepatocellular carcinomaHistone deacetylaseFibroblast growth factor receptor 4ApoptosisCombination therapyInternal medicinePharmacologyOncologyFibroblast growth factor receptorReceptorSorafenibFibroblast growth factorBiologyHistoneBiochemistryGeneHistone Deacetylase Inhibitors ResearchFibroblast Growth Factor ResearchAngiogenesis and VEGF in Cancer